• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH LACTATE DEHYDROGENASE (LDH); NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH LACTATE DEHYDROGENASE (LDH); NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE Back to Search Results
Model Number 2P56-22
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/16/2021
Event Type  malfunction  
Event Description
The customer identified falsely elevated lactate dehydrogenase results.The customer uses the reference range 125u/l to 243 u/l.The following information was provided: sample 1 initial result 218 u/l, repeated 349 u/l.Sample 2 initial result 606 u/l, repeated 838 u/l.The customer noted that the initial results were reported to the physician and have not been questioned.No impact to patient management was reported.
 
Manufacturer Narrative
No identifier or patient demographic information was provided.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
An investigation was performed for lactate dehydrogenase (ldh) list number 2p56-22 lot 44858un21.A review of tickets was performed and found no other tickets with the same erratic results issue for the reagent lot.A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.A review of the manufacturing documentation did not identify any issues associated with the complaint issue.A review of labeling concluded that the issue is sufficiently addressed.Based on the investigation no systemic issue or deficiency of the lactate dehydrogenase (ldh) list number 2p56-22 lot 44858un21 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LACTATE DEHYDROGENASE (LDH)
Type of Device
NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
christian lee
100 abbott park road
dept. 09b9, lc cp01-3
abbott park, IL 60064-3537
2246682940
MDR Report Key12745826
MDR Text Key283180762
Report Number3002809144-2021-00630
Device Sequence Number1
Product Code CFJ
UDI-Device Identifier00380740161460
UDI-Public00380740161460
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/08/2022
Device Model Number2P56-22
Device Catalogue Number02P56-22
Device Lot Number44858UN21
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/19/2021
Initial Date FDA Received11/03/2021
Supplement Dates Manufacturer Received11/08/2021
Supplement Dates FDA Received11/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/22/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC C8 PROC MOD, 01G06-11, C803721; ARC C8 PROC MOD, 01G06-11, C803721
-
-